Cost-effectiveness analysis of diagnostic options for Pneumocystis pneumonia (PCP)

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Harris, Julie R ^a   Marston, Barbara J ^b   Sangrujee, Nalinee ^b   DuPlessis, Desiree ^c   Park, Benjamin ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; TOLONIUM CHLORIDE; ANTIINFECTIVE AGENT;

ARTICLE; CALCOFLUOR WHITE STAIN; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST PER LIFE YEAR GAIN; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIFF QUICK; DRUG TREATMENT FAILURE; ECONOMIC EVALUATION; GROCOTT METHENAMINE SILVER STAIN; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOFLUORESCENCE TEST; LUNG LAVAGE; MAJOR CLINICAL STUDY; NESTED POLYMERASE CHAIN REACTION; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM EXAMINATION; STAINING; THORAX RADIOGRAPHY; AIDS RELATED COMPLEX; COST OF ILLNESS; DIAGNOSTIC PROCEDURES; DRUG EFFECT; ECONOMICS; GENETICS; METABOLISM; METHODOLOGY; MICROBIOLOGY; PNEUMOCYSTIS JIROVECI; REPRODUCIBILITY; SPUTUM;

PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL LABORATORY TECHNIQUES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HUMANS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; STAINING AND LABELING; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 80051673635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023158     Document Type: Article

References (111)

1. Krajicek BJ, Thomas CF Jr, Limper AH, (2009) Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin Chest Med 30: 265-278 vi.
2. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, et al. (2000) Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 30 (Suppl 1): S5-14.
3. Kelley CF, Checkley W, Mannino DM, Franco-Paredes C, Del Rio C, et al. (2009) Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005). Chest 136: 190-197.
4. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
5. Serraino D, Puro V, Boumis E, Angeletti C, Girardi E, et al. (2003) Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS: Europe, 1993-2000. AIDS 17: 2109-2116.
6. Graham SM, Mtitimila EI, Kamanga HS, Walsh AL, Hart CA, et al. (2000) Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet 355: 369-373.
7. Madhi SA, Cutland C, Ismail K, O'Reilly C, Mancha A, et al. (2002) Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Clin Infect Dis 35: 1120-1126.
8. Ruffini DD, Madhi SA, (2002) The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS 16: 105-112.
9. Zar HJ, Dechaboon A, Hanslo D, Apolles P, Magnus KG, et al. (2000) Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus. Pediatr Infect Dis J 19: 603-607.
10. Bakeera-Kitaka S, Musoke P, Downing R, Tumwine JK, (2004) Pneumocystis carinii in children with severe pneumonia at Mulago Hospital, Uganda. Ann Trop Paediatr 24: 227-235.
11. Fisk DT, Meshnick S, Kazanjian PH, (2003) Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis 36: 70-78.
12. Aderaye G, Bruchfeld J, Olsson M, Lindquist L, (2003) Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia. AIDS 17: 435-440.
13. Hargreaves NJ, Kadzakumanja O, Phiri S, Lee CH, Tang X, et al. (2001) Pneumocystis carinii pneumonia in patients being registered for smear-negative pulmonary tuberculosis in Malawi. Trans R Soc Trop Med Hyg 95: 402-408.
14. Worodria W, Okot-Nwang M, Yoo SD, Aisu T, (2003) Causes of lower respiratory infection in HIV-infected Ugandan adults who are sputum AFB smear-negative. Int J Tuberc Lung Dis 7: 117-123.
15. Aderaye G, Bruchfeld J, Aseffa G, Nigussie Y, Melaku K, et al. (2007) Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia. Scand J Infect Dis 39: 1045-1053.
16. Chakaya JM, Bii C, Ng'ang'a L, Amukoye E, Ouko T, et al. (2003) Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya. East Afr Med J 80: 30-35.
17. Ikeogu MO, Wolf B, Mathe S, (1997) Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 76: 124-128.
18. Jeena PM, Coovadia HM, Chrystal V, (1996) Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr 16: 361-368.
19. Lucas SB, Peacock CS, Hounnou A, Brattegaard K, Koffi K, et al. (1996) Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ 312: 335-338.
20. Malin AS, Gwanzura LK, Klein S, Robertson VJ, Musvaire P, et al. (1995) Pneumocystis carinii pneumonia in Zimbabwe. Lancet 346: 1258-1261.
21. Lumbiganon P, Kosalaraksa P, Loapaiboon M, (2000) Survival of children with AIDS: experience in a university hospital in northeast Thailand. J Med Assoc Thai 83: 652-656.
22. Bhoopat L, Thamprasert K, Chaiwun B, Attasiri C, Vithayasai P, et al. (1994) Histopathologic spectrum of AIDS-associated lesions in Maharaj Nakorn Chiang Mai Hospital. Asian Pac J Allergy Immunol 12: 95-104.
23. Le Minor O, Germani Y, Chartier L, Lan NH, Lan NT, et al. (2008) Predictors of pneumocystosis or tuberculosis in HIV-infected Asian patients with AFB smear-negative sputum pneumonia. J Acquir Immune Defic Syndr 48: 620-627.
24. Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, et al. (2004) Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 10: 1713-1720.
25. Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, et al. (2009) Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation 88: 135-141.
26. Gerhart JL, Kalaaji AN, (2009) Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications. J Am Acad Dermatol 62: 957-961.
27. Contini C, Villa MP, Romani R, Merolla R, Delia S, et al. (1998) Detection of Pneumocystis carinii among children with chronic respiratory disorders in the absence of HIV infection and immunodeficiency. J Med Microbiol 47: 329-333.
28. Gupta R, Mirdha BR, Guleria R, Kumar L, Samantaray JC, et al. (2009) Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jirovecii in respiratory clinical specimens. Diagn Microbiol Infect Dis 64: 381-388.
29. Helweg-Larsen J, Jensen JS, Benfield T, Svendsen UG, Lundgren JD, et al. (1998) Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples. J Clin Microbiol 36: 2068-2072.
30. Larsen HH, Masur H, Kovacs JA, Gill VJ, Silcott VA, et al. (2002) Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol 40: 490-494.
31. Aderaye G, Woldeamanuel Y, Asrat D, Lebbad M, Beser J, et al. (2008) Evaluation of Toluidine Blue O staining for the diagnosis of Pneumocystis jiroveci in expectorated sputum sample and bronchoalveolar lavage from HIV-infected patients in a tertiary care referral center in Ethiopia. Infection 36: 237-243.
32. Alvarez F, Bandi V, Stager C, Guntupalli KK, (1997) Detection of Pneumocystis carinii in tracheal aspirates of intubated patients using calcofluor-white (Fungi-Fluor) and immunofluorescence antibody (Genetic Systems) stains. Crit Care Med 25: 948-952.
33. Baselski VS, Robison MK, Pifer LW, Woods DR, (1990) Rapid detection of Pneumocystis carinii in bronchoalveolar lavage samples by using Cellufluor staining. J Clin Microbiol 28: 393-394.
34. Caliendo AM, Hewitt PL, Allega JM, Keen A, Ruoff KL, et al. (1998) Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens. J Clin Microbiol 36: 979-982.
35. Carmichael A, Bateman N, Nayagam M, (1991) Examination of induced sputum in the diagnosis of Pneumocystis carinii pneumonia. Cytopathology 2: 61-66.
36. Cartwright CP, Nelson NA, Gill VJ, (1994) Development and evaluation of a rapid and simple procedure for detection of Pneumocystis carinii by PCR. J Clin Microbiol 32: 1634-1638.
37. Gosey LL, Howard RM, Witebsky FG, Ognibene FP, Wu TC, et al. (1985) Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia. J Clin Microbiol 22: 803-807.
38. Kovacs JA, Ng VL, Masur H, Leoung G, Hadley WK, et al. (1988) Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med 318: 589-593.
39. Larsen HH, Huang L, Kovacs JA, Crothers K, Silcott VA, et al. (2004) A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis 189: 1679-1683.
40. Lautenschlager I, Lyytikainen O, Jokipii L, Jokipii A, Maiche A, et al. (1996) Immunodetection of Pneumocystis carinii in bronchoalveolar lavage specimens compared with methenamine silver stain. J Clin Microbiol 34: 728-730.
41. Leigh TR, Gazzard BG, Rowbottom A, Collins JV, (1993) Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumonia. J Clin Pathol 46: 140-144.
42. Leigh TR, Parsons P, Hume C, Husain OA, Gazzard B, et al. (1989) Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet 2: 205-206.
43. Leigh TR, Wakefield AE, Peters SE, Hopkin JM, Collins JV, (1992) Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy. Transplantation 54: 468-470.
44. Lipschik GY, Gill VJ, Lundgren JD, Andrawis VA, Nelson NA, et al. (1992) Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet 340: 203-206.
45. Matos O, Costa MC, Lundgren B, Caldeira L, Aguiar P, et al. (2001) Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis 20: 573-575.
46. McWilliams T, Wells AU, Harrison AC, Lindstrom S, Cameron RJ, et al. (2002) Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis. Thorax 57: 1010-1014.
47. Metersky ML, Aslenzadeh J, Stelmach P, (1998) A comparison of induced and expectorated sputum for the diagnosis of Pneumocystis carinii pneumonia. Chest 113: 1555-1559.
48. Moonens F, Liesnard C, Brancart F, Van Vooren JP, Serruys E, (1995) Rapid simple and nested polymerase chain reaction for the diagnosis of Pneumocystis carinii pneumonia. Scand J Infect Dis 27: 358-362.
49. Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, et al. (2004) Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol 42: 3333-3335.
50. Raab SS, Cheville JC, Bottles K, Cohen MB, (1994) Utility of Gomori methenamine silver stains in bronchoalveolar lavage specimens. Mod Pathol 7: 599-604.
51. Ribes JA, Limper AH, Espy MJ, Smith TF, (1997) PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity. J Clin Microbiol 35: 830-835.
52. Roux P, Lavrard I, Poirot JL, Chouaid C, Denis M, et al. (1994) Usefulness of PCR for detection of Pneumocystis carinii DNA. J Clin Microbiol 32: 2324-2326.
53. Saksirisampant W, Eampokalap B, Chantharodevong R, Changthong R, (2002) Comparison of methods for identification of Pneumocystis carinii in bronchoalveolar lavage fluid. J Med Assoc Thai 85 (Suppl 1): S407-414.
54. Savoia D, Millesimo M, Cassetta I, Forno B, Caramello P, (1997) Detection of Pneumocystis carinii by DNA amplification in human immunodeficiency virus-positive patients. Diagn Microbiol Infect Dis 29: 61-65.
55. Sing A, Trebesius K, Roggenkamp A, Russmann H, Tybus K, et al. (2000) Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 38: 1461-1467.
56. Stratton N, Hryniewicki J, Aarnaes SL, Tan G, de la Maza LM, et al. (1991) Comparison of monoclonal antibody and calcofluor white stains for the detection of Pneumocystis carinii from respiratory specimens. J Clin Microbiol 29: 645-647.
57. Tamburrini E, Mencarini P, De Luca A, Maiuro G, Ventura G, et al. (1993) Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol 38: 449-453.
58. Alvarez-Martinez MJ, Miro JM, Valls ME, Moreno A, Rivas PV, et al. (2006) Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn Microbiol Infect Dis 56: 153-160.
59. Atzori C, Agostoni F, Angeli E, Mainini A, Orlando G, et al. (1998) Combined use of blood and oropharyngeal samples for noninvasive diagnosis of Pneumocystis carinii pneumonia using the polymerase chain reaction. Eur J Clin Microbiol Infect Dis 17: 241-246.
60. Atzori C, Angeli E, Agostoni F, Mainini A, Micheli V, et al. (1998) Biomolecular techniques to detect Pneumocystis carinii f. sp. hominis pneumonia in patients with acquired immunodeficiency syndrome. Int J Infect Dis 3: 76-81.
61. Bandt D, Monecke S, (2007) Development and evaluation of a real-time PCR assay for detection of Pneumocystis jiroveci. Transpl Infect Dis 9: 196-202.
62. Brancart F, Rodriguez-Villalobos H, Fonteyne PA, Peres-Bota D, Liesnard C, (2005) Quantitative TaqMan PCR for detection of Pneumocystis jiroveci. J Microbiol Methods 61: 381-387.
63. Chawla K, Martena S, Gurung B, Mukhopadhyay C, Varghese GK, et al. (2011) Role of PCR for diagnosing Pneumocystis jirovecii pneumonia in HIV-infected individuals in a tertiary care hospital in India. Indian J Pathol Microbiol 54: 326-329.
64. Chouaid C, Roux P, Lavard I, Poirot JL, Housset B, (1995) Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients. A clinical and cost-analysis study. Am J Clin Pathol 104: 72-75.
65. Chumpitazi BF, Flori P, Kern JB, Brenier-Pinchart MP, Hincky-Vitrat V, et al. (2011) Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia. Med Mycol (epub ahead of print).
66. Fillaux J, Malvy S, Alvarez M, Fabre R, Cassaing S, et al. (2008) Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. J Microbiol Methods 75: 258-261.
67. Flori P, Bellete B, Durand F, Raberin H, Cazorla C, et al. (2004) Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol 53: 603-607.
68. Helweg-Larsen J, Jensen JS, Lundgren B, (1997) Non-invasive diagnosis of Pneumocystis carinii pneumonia in haematological patients using PCR on oral washes. J Eukaryot Microbiol 44: 59S.
69. Hua L, Qin S, Wang A, Sheng R, Zhang K, (2002) [The diagnostic value of polymerase chain reaction for the detection of Pneumocystis carinii DNA from induced sputum samples]. Zhonghua Nei Ke Za Zhi 41: 610-612.
70. Huang SN, Fischer SH, O'Shaughnessy E, Gill VJ, Masur H, et al. (1999) Development of a PCR assay for diagnosis of Pneumocystis carinii pneumonia based on amplification of the multicopy major surface glycoprotein gene family. Diagn Microbiol Infect Dis 35: 27-32.
71. Huggett JF, Taylor MS, Kocjan G, Evans HE, Morris-Jones S, et al. (2008) Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients. Thorax 63: 154-159.
72. Lishimpi K, Kasolo F, Chintu C, Mwaba P, Mudenda V, et al. (2002) Identification of Pneumocystis carinii DNA in oropharyngeal mouth washes from AIDS children dying of respiratory illnesses. AIDS 16: 932-934.
73. Mathis A, Weber R, Kuster H, Speich R, (1997) Simplified sample processing combined with a sensitive one-tube nested PCR assay for detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 35: 1691-1695.
74. Nyamande K, Lalloo UG, York D, Naidoo M, Irusen EM, et al. (2005) Low sensitivity of a nested polymerase chain reaction in oropharyngeal washings for the diagnosis of Pneumocystis pneumonia in HIV-infected patients. Chest 128: 167-171.
75. Pinlaor S, Mootsikapun P, Pinlaor P, Phunmanee A, Pipitgool V, et al. (2004) PCR diagnosis of Pneumocystis carinii on sputum and bronchoalveolar lavage samples in immuno-compromised patients. Parasitol Res 94: 213-218.
76. Rabodonirina M, Raffenot D, Cotte L, Boibieux A, Mayencon M, et al. (1997) Rapid detection of Pneumocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected patients: use of a simple DNA extraction procedure and nested PCR. J Clin Microbiol 35: 2748-2751.
77. Rohner P, Jacomo V, Studer R, Schrenzel J, Graf JD, (2009) Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays. Infection 37: 261-265.
78. Tamburrini E, Ortona E, Visconti E, Margutti P, Mencarini P, et al. (1997) Detection of Pneumocystis carinii in oropharyngeal washings by PCR-SHELA and nested PCR. J Eukaryot Microbiol 44: 48S.
79. Torres J, Goldman M, Wheat LJ, Tang X, Bartlett MS, et al. (2000) Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: a blinded comparison to standard methods. Clin Infect Dis 30: 141-145.
80. Zingale A, Carrera P, Lazzarin A, Scarpellini P, (2003) Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjects. J Clin Microbiol 41: 2709-2712.
81. Cregan P, Yamamoto A, Lum A, VanDerHeide T, MacDonald M, et al. (1990) Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 28: 2432-2436.
82. Kirsch CM, Azzi RL, Yenokida GG, Jensen WA, (1990) Analysis of induced sputum in the diagnosis of Pneumocystis carinii pneumonia. Am J Med Sci 299: 386-391.
83. Ognibene FP, Shelhamer J, Gill V, Macher AM, Loew D, et al. (1984) The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. Am Rev Respir Dis 129: 929-932.
84. Pitchenik AE, Ganjei P, Torres A, Evans DA, Rubin E, et al. (1986) Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Respir Dis 133: 226-229.
85. Fischer S, Gill VJ, Kovacs J, Miele P, Keary J, et al. (2001) The use of oral washes to diagnose Pneumocystis carinii pneumonia: a blinded prospective study using a polymerase chain reaction-based detection system. J Infect Dis 184: 1485-1488.
86. Lu JJ, Chen CH, Bartlett MS, Smith JW, Lee CH, (1995) Comparison of six different PCR methods for detection of Pneumocystis carinii. J Clin Microbiol 33: 2785-2788.
87. Schneider M, Zwahlen M, Egger M, (2004) Natural history and mortality in HIV-positive individuals living in resource-poor settings: a literature review. ISPM University of Berne/University of Bristol Department of Social Medicine. Available at: http://data.unaids.org/pub/Periodical/2004/egger_unaids_hq_03_463871_2007_en.pdf. Accessed 18 July 2011.
88. Anglaret X, Chene G, Attia A, Toure S, Lafont S, et al. (1999) Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 353: 1463-1468.
89. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, et al. (1999) Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 353: 1469-1475.
90. Coopman SA, Johnson RA, Platt R, Stern RS, (1993) Cutaneous disease and drug reactions in HIV infection. N Engl J Med 328: 1670-1674.
91. Gordin FM, Simon GL, Wofsy CB, Mills J, (1984) Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100: 495-499.
92. Capra C, Monza GM, Meazza G, Ramella G, (2000) Trimethoprim-sulfamethoxazole-induced aseptic meningitis: case report and literature review. Intensive Care Med 26: 212-214.
93. Bijl AM, Van der Klauw MM, Van Vliet AC, Stricker BH, (1998) Anaphylactic reactions associated with trimethoprim. Clin Exp Allergy 28: 510-512.
94. Archontoulis NK, Staikou CV, (2009) Therapeutic failure in a renal transplant patient with Pneumocystis jiroveci pneumonia: a case report. Exp Clin Transplant 7: 129-132.
95. Iliades P, Meshnick SR, Macreadie IG, (2005) Analysis of Pneumocystis jirovecii DHPS alleles implicated in sulfamethoxazole resistance using an Escherichia coli model system. Microb Drug Resist 11: 1-8.
96. Nahimana A, Rabodonirina M, Bille J, Francioli P, Hauser PM, (2004) Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob Agents Chemother 48: 4301-4305.
97. Adrian PV, Klugman KP, (1997) Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 41: 2406-2413.
98. Chiller TM, Polyak CS, Brooks JT, Williamson J, Ochieng B, et al. (2009) Daily trimethoprim-sulfamethoxazole prophylaxis rapidly induces corresponding resistance among intestinal Escherichia coli of HIV-infected adults in Kenya. J Int Assoc Physicians AIDS Care (Chic) 8: 165-169.
99. Gwanzura L, Pasi C, Nathoo KJ, Hakim J, Gangaidzo I, et al. (2003) Rapid emergence of resistance to penicillin and trimethoprim-sulphamethoxazole in invasive Streptococcus pneumoniae in Zimbabwe. Int J Antimicrob Agents 21: 557-561.
100. Mandomando I, Jaintilal D, Pons MJ, Valles X, Espasa M, et al. (2009) Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique. Antimicrob Agents Chemother 53: 2450-2454.
101. Marais E, Aithma N, Perovic O, Oosthuysen WF, Musenge E, et al. (2009) Antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolates from South Africa. S Afr Med J 99: 170-173.
102. Onyango AO, Kenya EU, Mbithi JJ, Ng'ayo MO, (2009) Pathogenic Escherichia coli and food handlers in luxury hotels in Nairobi, Kenya. Travel Med Infect Dis 7: 359-366.
103. Vandenberg O, Nyarukweba DZ, Ndeba PM, Hendriksen RS, Barzilay EJ, et al. Microbiologic and clinical features of Salmonella species isolated from bacteremic children in eastern Democratic Republic of Congo. Pediatr Infect Dis J 29: 504-510.
104. Crans CA Jr, Boiselle PM, (1999) Imaging features of Pneumocystis carinii pneumonia. Crit Rev Diagn Imaging 40: 251-284.
105. Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, et al. (2002) Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 6: 55-63.
106. Nicolay N, (2008) Summary of Provincial HIV and AIDS Statistics for South Africa. Available at: http://www.metam.co.za/documents_v2/File/RedRibbon_2009/Provincial%20HIV%20and%20AIDS%20statistics%20for%202008.pdf. Accessed 18 July 2011.
107. UNAIDS (2011) AIDSinfo Country Fact Sheets: South Africa. Available at: http://www.unaids.org/en/dataanalysis/tools/aidsinfo/countryfactsheets/. Accessed 18 July 2011.
108. Boehme CC, Nabeta P, Henostroza G, Raqib R, Rahim Z, et al. (2007) Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 45: 1936-1940.
109. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005-1015.
110. Francois P, Bento M, Hibbs J, Bonetti EJ, Boehme CC, et al. (2011) Robustness of loop-mediated isothermal amplification reaction for diagnostic applications. FEMS Immunol Med Microbiol 62: 41-48.
111. Kubo T, Agoh M, Mai le Q, Fukushima K, Nishimura H, et al. (2010) Development of a reverse transcription-loop-mediated isothermal amplification assay for detection of pandemic (H1N1) 2009 virus as a novel molecular method for diagnosis of pandemic influenza in resource-limited settings. J Clin Microbiol 48: 728-735.